You are here
BREONICS, INC.
UEI: N/A
# of Employees: 6
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: Yes
Award Charts
Award Listing
-
The Potential to Immunocloak Renal Allografts
Amount: $2,922,234.00DESCRIPTION provided by applicant The focus of this project is a novel immunomodifying therapy that provides protection from early allograft rejection in the absence of the standard toxic systemic ...
SBIRPhase II2014Department of Health and Human Services National Institutes of Health -
Cell therapy for Repairing Warm Ischemically Damaged Kidneys
Amount: $600,000.00DESCRIPTION provided by applicant The goal of this project is address a large unmet medical need by providing more kidneys for transplant For the andgt patients with end stage renal diseas ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health -
Potential to Immunocloak Renal Allografts
Amount: $400,000.00DESCRIPTION (provided by applicant): This proposal is being resubmitted for funding consideration by the Advanced NIAID Technology SBIR Program (PA-06-134) that provides Phase 1 funding of up to 300, ...
SBIRPhase I2009Department of Health and Human Services National Institutes of Health -
ORGAN SPECIFIC IMMUNOSUPRESSION
Amount: $100,000.00DESCRIPTION: BREONICS is developing ENDOMATRIX, a natural, matrix membrane, capable of serving as an immunomodifying agent rendering allografts nonimmunogenic and nonthrombog ...
SBIRPhase I2001Department of Health and Human Services National Institutes of Health